We are live on !
Find out more
Rangeley Capital Portfolio holdings
AUM
$109M
Turnover
49.06%
1-Year Est. Return
97.13%
This Fund
S&P 500
This Quarter Est. Return
+34.11%
1 Year Est. Return
+97.13%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$109M
AUM Growth
+$6.53M
(+6.3%)
Cap. Flow
-$6.26M
Cap. Flow % of AUM
Cap. Flow %
-5.72%
Top 10 Holdings %
Top 10 Hldgs %
32.08%
Holding
212
New
75
Increased
28
Reduced
43
Closed
29
Avg Time Held
Equity + Options
0.4
years
Top 10 Avg Time Held
Equity + Options
0.3
years
Top 20 Avg Time Held
Equity + Options
0.4
years
Avg Time Held Equity only
0.4
years
Top 10 Avg Time Held Equity only
0.3
years
Top 20 Avg Time Held Equity only
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nomad Foods
NOMD
|
+$1.34M |
| 2 |
Mountain Lake Acquisition Corp II
MLAA
|
+$1.27M |
| 3 |
Distribution Solutions Group
DSGR
|
+$1.26M |
| 4 |
enGene Therapeutics
ENGN
|
+$1.24M |
| 5 |
Abivax
ABVX
|
+$1.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Revolution Medicines
RVMD
|
+$8.47M |
| 2 |
Leggett & Platt
LEG
|
+$2.1M |
| 3 |
Icon
ICLR
|
+$1.96M |
| 4 |
Kezar Life Sciences
KZR
|
+$1.8M |
| 5 |
Mister Car Wash
MCW
|
+$1.54M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.11% |
| 2 | Consumer Discretionary | 14.33% |
| 3 | Financials | 12.51% |
| 4 | Miscellaneous | 10.11% |
| 5 | Real Estate | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CCIX
176
DELISTED
Churchill Capital Corp IX
CCIX
| $17.4K | 0.02% |
+1,602
| New | +$17.3K |
2026 Q2
0 quarters
|
|
177
Apogee Acquisition Corp Units
AACPU
$267M
| $15.9K | 0.01% |
+1,555
| New | +$15.8K |
2026 Q2
0 quarters
|
|
178
Praetorian Acquisition Corp
PTOR
$338M
| $15.8K | 0.01% |
+1,592
| New | +$15.7K |
2026 Q2
0 quarters
|
|
179
Barnwell Industries
BRN
$12.6M
| $15.2K | 0.01% |
+15,000
| New | +$16.3K |
2026 Q2
0 quarters
|
|
180
AI Financial Corp
AIFC
$37M
| $14.6K | 0.01% |
25,000
-1,000
| -4% | -$838 |
2025 Q3
3 quarters
|
|
181
CALL
ProFrac Holding
ACDC
$818M
| $11.6K | 0.01% |
+2,000
| New | +$13.5K |
2026 Q2
0 quarters
|
|
182
Roman DBDR Acquisition Corp II Warrants
DRDBW
| $11.4K | 0.01% |
+1,083
| New | +$241 |
2026 Q2
0 quarters
|
|
183
Inflection Point Acquisition Corp VI Units
IPFXU
| $7.67K | 0.01% |
+701
| New | +$7.3K |
2026 Q2
0 quarters
|
|
184
Aimco
AIV
$238M
| – | – |
-90,000
| Closed | -$366K | – |
|
185
Burford Capital
BUR
$725M
| – | – |
-11,569
| Closed | -$52.3K | – |
|
186
DELISTED
Clear Channel Outdoor Holdings
CCO
| – | – |
-18,600
| Closed | -$44.1K | – |
|
|
CNTA
187
DELISTED
Centessa Pharmaceuticals
CNTA
| – | – |
-9,000
| Closed | -$357K | – |
|
188
DELISTED
Clearwater Analytics
CWAN
| – | – |
-28,000
| Closed | -$662K | – |
|
|
ELME
189
DELISTED
Elme Communities
ELME
| – | – |
-658,000
| Closed | -$1.32M | – |
|
|
EM
190
DELISTED
Smart Share Global Ltd
EM
| – | – |
-307,000
| Closed | -$347K | – |
|
191
Monte Rosa Therapeutics
GLUE
$900M
| – | – |
-27,016
| Closed | -$444K | – |
|
192
Hilton Grand Vacations
HGV
$2.72B
| – | – |
-25,000
| Closed | -$978K | – |
|
193
DELISTED
Hologic
HOLX
| – | – |
-13,000
| Closed | -$983K | – |
|
|
194
Icon
ICLR
$14.2B
| – | – |
-17,700
| Closed | -$1.96M | – |
|
195
Kiora Pharmaceuticals
KPRX
$10M
| – | – |
-10,000
| Closed | -$19.3K | – |
|
196
DELISTED
Kennedy-Wilson Holdings
KW
| – | – |
-97,000
| Closed | -$1.05M | – |
|
|
197
DELISTED
Kezar Life Sciences
KZR
| – | – |
-243,073
| Closed | -$1.8M | – |
|
198
Standard BioTools
LAB
$245M
| – | – |
-50,000
| Closed | -$46K | – |
|
|
199
DELISTED
Leggett & Platt
LEG
| – | – |
-213,000
| Closed | -$2.1M | – |
|
200
LENSAR
LNSR
$72.9M
| – | – |
-63,000
| Closed | -$375K | – |
|
Similar funds
S2L
Rangeley Capital's Q2 2026 Portfolio in Review
As of Q2 2026, Rangeley Capital held 212 positions worth $109M, up 6.3% from $103M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Rangeley Capital withdrew a net $6.26M in Q2 2026, closing 29 positions and reducing 43 holdings. Its most notable exit was Leggett & Platt, an estimated $2.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Rangeley Capital opened a new position in Nomad Foods worth $1.48M.
- Rangeley Capital's largest Q2 2026 buy was Nomad Foods: 135,000 shares worth $1.48M.
- Rangeley Capital added most to Distribution Solutions Group in Q2 2026, an estimated $1.26M increase.
- Rangeley Capital's biggest Q2 2026 reduction was Revolution Medicines, cutting an estimated $8.47M.
- Rangeley Capital fully exited Leggett & Platt in Q2 2026, selling an estimated $2.1M.
- Rangeley Capital's ten largest holdings make up 32% of its $109M portfolio in Q2 2026.
- Rangeley Capital opened 75 new positions and closed 29 in Q2 2026.
- Rangeley Capital's portfolio value rose 6.3% quarter-over-quarter to $109M.
Based on Rangeley Capital's 13F filing for Q2 2026, filed 14 Aug 2026.